Document Detail


Effects of prescribed medications on cognition and behavior in frontotemporal lobar degeneration.
MedLine Citation:
PMID:  20930186     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A retrospective chart review of 21 patients meeting core clinical criteria for behavioral or aphasic variants of frontotemporal lobar degeneration (FTLD) was conducted. Data recorded included Folstein Mini-Mental State Examination (MMSE) scores, medications prescribed, and subjective reports of behavioral symptoms from each visit. Behaviors were graded on a scale from 1 to 3 and totaled for each visit. Changes in MMSE and behavior scores between visits 1 month and 6 months apart where a new medication was started were analyzed using a paired t test and were compared between medication classes using an unpaired t test. Acetylcholinesterase inhibitors (AChEIs) were associated with a decrease in MMSE scores by 1.6 (P = .02) and an increase in total behavior scores by 1.0 (P = .03). Mean MMSE and behavior scores were statistically more improved by selective serotonin reuptake inhibitors than AChEIs (P = .04). This data suggest a potential worsening of objective measures of cognitive and behavioral symptoms in FTLD with AChEI treatment.
Authors:
David Irwin; Carol F Lippa; Andrea Rosso
Related Documents :
17053486 - The importance of rhinitis on sleep, daytime somnolence, productivity and fatigue.
10856166 - Allergic rhinitis: treating the adult.
15190726 - Hypnosis and existential psychotherapy with end-stage terminally ill patients.
15156966 - Discontinuation and reinstitution of medications during the perioperative period.
14609686 - Predicting outcomes of transforaminal epidural injections for sciatica.
12943646 - Does reporting of plain chest radiographs affect the immediate management of patients a...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of Alzheimer's disease and other dementias     Volume:  25     ISSN:  1938-2731     ISO Abbreviation:  Am J Alzheimers Dis Other Demen     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-08     Completed Date:  2011-01-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101082834     Medline TA:  Am J Alzheimers Dis Other Demen     Country:  United States    
Other Details:
Languages:  eng     Pagination:  566-71     Citation Subset:  IM    
Affiliation:
Department of Neurology, Drexel University College of Medicine, Philadelphia, PA 19102, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Behavior / drug effects
Cholinesterase Inhibitors / therapeutic use*
Cognition / drug effects*
Cognition Disorders / therapy
Dopamine Agents / therapeutic use*
Female
Frontotemporal Lobar Degeneration / drug therapy*
Humans
Male
Middle Aged
Neuropsychological Tests
Retrospective Studies
Serotonin Uptake Inhibitors / therapeutic use*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Cholinesterase Inhibitors; 0/Dopamine Agents; 0/Serotonin Uptake Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ten steps in training volunteer support group facilitators.
Next Document:  The generation effect in patients with mild cognitive impairment.